Molecular Diagnostics picks up pace
Molecular diagnostics (MDx) is witnessing a fast-paced growth for detection of infectious micro-organisms as well as ailments like oncology. Laboratories are relying on MDx as a powerful tool for improving efficiency, with early diagnosis and accurate detection.
Molecular tests help in identifying infections or
ailments at early stages; enabling clinicians with information for personalized
and precise treatments. Accurate and early diagnosis prevents further
transmission, and rationalizes antibiotic use, thereby minimizes chances for antibiotic
resistance.
Polymerase Chain Reaction (PCR)
PCR applies
primer mediated enzymatic amplification of DNA to synthesize new strand of DNA
complementary to the targeted template strand. Of late, quantitative
real-time PCR (qPCR) is gaining popularity for detection of pathogens. This
technology requires less than 5 hours, is simple, reproducible, and offers a
quantitative output.
Isothermal Amplification
Methods
Current advancement in PCRs and development of novel enzymes has led to the adoption of isothermal amplification methods, including loop-mediated isothermal amplification (LAMP) and polymerase spiral reaction (PSR). LAMP is a unique nucleic acid amplification technique that amplifies few copies of DNA into billion copies within an hour under isothermal conditions (constant temperature) with greater specificity.
Next Generation Sequencing (NGS)
Technology
NGS offers broad investigations of the bacterial genomes and can be readily applied in clinical microbiology. NGS can generate high quality and lower noise background sequence data, is therefore a preferred tool, for identification of Single Nucleotide Polymorphisms (SNPs), for detecting mutant strains.
POCT - Molecular
Diagnostic
advancements are further enabling development of systems with cartridges that can
be run without stringent clean room requirements while minimizing risks related
to contamination, generally associated with molecular assays.
Molecular immune-assays based on CRISPR and CAS9 and lateral-flow detection
could lead the way and gain good market share in the near future.
The
advantage
Molecular assays can target multiple
gene segments in one reaction. Multiplexing provides several answers to
clinicians for identifying the pathogen, and quantitative data provided helps
in therapeutic drug monitoring. Industries find it easy to scale molecular
assays, as oligosaccharides, enzymes and probes are readily available and once
optimized, menu expansion is easy too.
Stringent transportation and storage
requirements for molecular assays often make these tests less accessible and
affordable for laboratories in rural areas. However, more and more companies
are building capabilities to lyophilize reagents to mitigate these challenges.
To conclude, Indian diagnostic companies
are geared up to match MNCs for developing more versatile and advanced
molecular products customized for local settings.
Dr. Manoj Chugh
Associate Vice
President – R&D
Transasia Bio-Medicals Ltd.
Comments
Post a Comment